Brain glucose metabolism in chronic marijuana users at baseline and during marijuana intoxication
- PMID: 8797240
- DOI: 10.1016/0925-4927(96)02817-x
Brain glucose metabolism in chronic marijuana users at baseline and during marijuana intoxication
Abstract
Despite the widespread abuse of marijuana, knowledge about its effects in the human brain is limited. Brain glucose metabolism with and without delta 9 tetrahydrocannabinol (THC) (main psychoactive component of marijuana) was evaluated in eight normal subjects and eight chronic marijuana abusers with positron emission tomography. At baseline, marijuana abusers showed lower relative cerebellar metabolism than normal subjects. THC increased relative cerebellar metabolism in all subjects, but only abusers showed increases in orbitofrontal cortex, prefrontal cortex, and basal ganglia. Cerebellar metabolism during THC intoxication was significantly correlated with the subjective sense of intoxication. The decreased cerebellar metabolism in marijuana abusers at baseline could account for the motor deficits previously reported in these subjects. The activation of orbitofrontal cortex and basal ganglia by THC in the abusers but not in the normal subjects could underlie one of the mechanisms leading to the drive and the compulsion to self-administer the drug observed in addicted individuals.
Similar articles
-
Cerebellar metabolic activation by delta-9-tetrahydro-cannabinol in human brain: a study with positron emission tomography and 18F-2-fluoro-2-deoxyglucose.Psychiatry Res. 1991 May;40(1):69-78. doi: 10.1016/0925-4927(91)90030-t. Psychiatry Res. 1991. PMID: 1658842
-
Brain imaging study of the acute effects of Delta9-tetrahydrocannabinol (THC) on attention and motor coordination in regular users of marijuana.Psychopharmacology (Berl). 2008 Jan;196(1):119-31. doi: 10.1007/s00213-007-0940-7. Epub 2007 Sep 26. Psychopharmacology (Berl). 2008. PMID: 17899017
-
Effects of methylphenidate on regional brain glucose metabolism in humans: relationship to dopamine D2 receptors.Am J Psychiatry. 1997 Jan;154(1):50-5. doi: 10.1176/ajp.154.1.50. Am J Psychiatry. 1997. PMID: 8988958
-
A review of differences between basal ganglia and cerebellar control of movements as revealed by functional imaging studies.Brain. 1998 Aug;121 ( Pt 8):1437-49. doi: 10.1093/brain/121.8.1437. Brain. 1998. PMID: 9712006 Review.
-
Marijuana, receptors and immunomodulation.Adv Exp Med Biol. 1995;373:103-13. doi: 10.1007/978-1-4615-1951-5_15. Adv Exp Med Biol. 1995. PMID: 7668140 Review.
Cited by
-
Tetrahydrocannabinol and dopamine D1 receptor.Front Neurosci. 2024 Feb 14;18:1360205. doi: 10.3389/fnins.2024.1360205. eCollection 2024. Front Neurosci. 2024. PMID: 38419666 Free PMC article. Review.
-
Perturbation of 3D nuclear architecture, epigenomic aging and dysregulation, and cannabinoid synaptopathy reconfigures conceptualization of cannabinoid pathophysiology: part 2-Metabolome, immunome, synaptome.Front Psychiatry. 2023 Oct 3;14:1182536. doi: 10.3389/fpsyt.2023.1182536. eCollection 2023. Front Psychiatry. 2023. PMID: 37854446 Free PMC article. Review.
-
Perturbation of 3D nuclear architecture, epigenomic dysregulation and aging, and cannabinoid synaptopathy reconfigures conceptualization of cannabinoid pathophysiology: part 1-aging and epigenomics.Front Psychiatry. 2023 Sep 5;14:1182535. doi: 10.3389/fpsyt.2023.1182535. eCollection 2023. Front Psychiatry. 2023. PMID: 37732074 Free PMC article. Review.
-
Targeting corticostriatal transmission for the treatment of cannabinoid use disorder.Trends Pharmacol Sci. 2023 Aug;44(8):495-506. doi: 10.1016/j.tips.2023.05.003. Epub 2023 Jun 16. Trends Pharmacol Sci. 2023. PMID: 37331914 Free PMC article. Review.
-
Differences in Inhibitory Control and Resting Brain Metabolism between Older Chronic Users of Tetrahydrocannabinol (THC) or Cannabidiol (CBD)-A Pilot Study.Brain Sci. 2022 Jun 23;12(7):819. doi: 10.3390/brainsci12070819. Brain Sci. 2022. PMID: 35884627 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Medical